Monday, October 18, 2021
Mitochondrial Health

ILC 2021 Press Conference 25 June – NAFLD / NASH

ILC 2021 with its 3rd and final press conference on NAFLD / NASH.

Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021

New data released on trials involving RNAi therapeutics, antivirals and structurally engineered fatty acids to treat NAFLD

Read the Media Release



Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *